New possibilities of using the FreeStyle Libre Flash-glucose monitoring system. FreeStyle Libre software ecosystem in Russia


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Currently, on the territory of the Russian Federation, the use of the FreeStyle Libre Flash-glucose monitoring system is possible only in combination with a scanner, which must be brought to the sensor at a distance of less than 4 cm to read the data. In 2021, the Abbott is launching software on the Russian market designed to receive data from a sensor, store them, analyze the received data and transfer them to medical specialists or other persons at the request of the patient. The article presents the advantages of new software products and the opportunities they provide.

Full Text

Restricted Access

About the authors

Nikolai A. Demidov

Hospital in Moskovsky town of the Moscow Healthcare Department

Email: nicolay13@mail.ru
Cand. Sci. (Med.), endocrinologist build. 7, microdistr. 3, Moscovsky City, Moscow 108811, Russian Federation

References

  1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-86. doi: 10.1056/NEJM199309303291401.
  2. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837-53.
  3. Анциферов М.Б., Галстян Г.Р., Зилов А.В. и др. Резолюция по итогам первой рабочей встречи научно-консультативного совета по вопросу «актуальные проблемы вариабельности гликемии ка нового критерия гликемического контроля и безопасности терапии сахарного диабета». Сахарный диабет. 2019;22(3):281-88.
  4. Danne T., Nimri R., Battelino T., et al. International Consensus on Use of Continuous Glucose Monitoring. Diabetes Care. 2017;40:1631-40. Doi: 10.2337/ dc17-1600.
  5. The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med. 2008;359:1464-76. doi: 10.1056/NEJMoa0805017.
  6. Beck R.W., Riddlesworth T., Ruedy K., et al. Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections. The DIAMOND randomized clinical trial. JAMA. 2017;317:371-78. doi: 10.1001/jama.2016.19975.
  7. Beck R.W., Riddlesworth T., Ruedy K., et al. Continuous glucose monitoring versus usual care in patients with type 2 diabetes receiving multiple daily insulin injections: a randomized trial. Ann Intern Med. 2017;167:365-74. doi: 10.7326/M16-2855.
  8. Lind M., Polonsky W., Hirsch I.B., et al. Continuous glucose monitoring vs conventional therapy for glycemic control in adults with type 1 diabetes treated with multiple daily insulin injections: the GOLD randomized clinical trial. JAMA. 2017;317:379-87. doi: 10.1001/jama.2016.19976.
  9. Beck R.W., Riddlesworth T., Ruedy K., et al. DIAMOND Study Group. Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections The DIAMOND Randomized Clinical Trial. JAMA. 2017;317(4):371-78. doi: 10.1001/jama.2016.19975.
  10. Polonsky W., Hirsch I.B., Heise T., et al. Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections The GOLD Randomized Clinical Trial Marcus Lind. JAMA. 2017;317(4):379-87. doi: 10.1001/jama.2016.19976. [Corrected on May 9, 2017].
  11. Beck R.W., Riddlesworth T.D., Ruedy K., et al. DIAMOND Study Group*. Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections. Ann Intern Med. 2017;167(6):365-74. doi: 10.7326/M16-2855.
  12. Campbell F., Murphy N., Stewart C., et al. Outcomes of using flash glucose monitoring technology by children and young people with type 1 diabetes in a single arm study. Paediatr Diabet. 2018;19(7):1294-301. doi: 10.1111/pedi.12735.
  13. Bolinder J., Antuna R., Geelhoed-Duijvestijn P., et al. Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, nonmasked, randomised controlled trial. Lancet. 2016;388:2254-63. doi: 10.1016/S0140-6736(16)31535-5.
  14. Haak T., Hanaire H., Ajjan R., et al. Flash glucosesensing technology as a replacement for blood glucose monitoring for the management of insulintreated type 2 diabetes: a multicenter, open-label randomized controlled trial. Diabet Ther. 2017;8:55-73. doi: 10.1007/s13300-016-0223-6.
  15. Bidonde J., Fagerlund B.C., Fr0nsdal K.B., et al. FreeStyle Libre Flash Glucose Self-Monitoring System: A Single-Technology Assessment [Internet]. Report from the Norwegian Institute of Public Health No. 2017-07. Oslo, Norway: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2017 Aug 21.
  16. Stroup D.F., Berlin J.A., Morton S.C., et al. Metaanalysis of observational studies in epidemiology: a proposal for reporting. JAMA. 2000;283:2008-12. doi: 10.1001/jama.283.15.2008.
  17. von Elm E., Altman D.G., Egger M., et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg. 2014;12:1495-99. doi: 10.1016/j.ijsu.2014.07.013.
  18. Evans M., Welsh Z., Ells S., Seibold A. The Impact of Flash Glucose Monitoring on Glycaemic Control as Measured by HbA1C A Meta-analysis of Clinical Trials and Real-World Observational Studies. Diabet Ther. 2020;11:83-95. doi: 10.1007/s13300-019-00720-0.
  19. Eeg-Olofsson K., Svensson A.-M., Franzén S., et al. Sustainable HbA1c Decrease at 12 Months for Adults with Type 1 and Type 2 Diabetes Using the FreeStyle Libre System: A Study within the National Diabetes Register in Sweden. Diabet. 2020;69(Suppl. 1). doi: 10.2337/db20-74-LB.
  20. Roussel R., Guerci B., Vicaut E., et al. Dramatic Drop in Ketoacidosis Rate after Free Style Libre System Initiation in Type 1 and Type 2 Diabetes in France, Especially in People with Low SelfMonitoring of Blood Glucose (SMBG): A Nationwide Study. Diabet. 2020;69(Suppl. 1). doi: 10.2337/db20-68-OR.
  21. Battelino T., et al. Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range. Diabet Care. ADA, 2019 June 7. doi: 10.2337/dci19-0028.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies